poisar

Stocks · News reference

Wells Fargo Maintains Amrize at Equal-Weight, Lowers Price Target to $39

Fiscal.ai

Wells Fargo has adjusted its price target for Amrize to $39 from $40, while maintaining an Equal-Weight rating.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading